Skip to main content

Proceeding contribution from Caroline Lucas (Green Party) in the House of Commons on Thursday, 16 December 2010. It occurred during Adjournment debate and Backbench debate on Drugs Policy.


Drugs Policy

I agree with the hon. Gentleman that our position needs to be based on science and evidence, and regularly reviewed. It is precisely that kind of approach that characterises the RIOTT programmes that I mentioned. I have seen the results in my own constituency and I passionately hope that such programmes will be made more available across the country. In conclusion, hon. Members will appreciate that to consider the legal regulation of drugs represents a huge shift in thinking. As such, any regulation should be brought in slowly and carefully, step by step, with each phase properly assessed before moving on to the next one. I mentioned earlier that, sadly, any debate on drug strategy is all too often derailed by knee-jerk reaction and an assertion that attempting to question the existing prohibition-based approach is tantamount to dishing pills out like candy to school children. I hope that hon. Members will not take that kind of simplistic approach today. I am sure that they will not as the nature of the debate has been very constructive. I hope that we can build a cross-party approach to drug regulation that will be open to learning from the example of countries such as Portugal, which primarily treats drugs policy as a health concern. I would certainly advocate an entirely joined-up approach to drug abuse under the auspices of a single unit in the Department of Health, rather than, as at the moment, the Home Office. I hope it is clear that being in favour of drug controls is entirely consistent with the objective of reducing drug-related harm, and that continuing to support prohibition actively works in the other direction.


Secondary information

Type
Proceeding contribution
Reference
520 c358-9WH 
Session
2010-12
Chamber / Committee
Westminster Hall
Subjects
Drugs Misuse Policy Regulation Advisory Council on the Misuse of Drugs
Link
View this Proceeding contribution on www.publications.parliament.uk